Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series

M. H.N. Chagas, A. L. Eckeli, A. W. Zuardi, M. A. Pena-Pereira, M. A. Sobreira-Neto, E. T. Sobreira, M. R. Camilo, M. M. Bergamaschi, C. H. Schenck, J. E.C. Hallak, V. Tumas, J. A.S. Crippa

Research output: Contribution to journalArticlepeer-review

205 Scopus citations

Abstract

What is known and objective Cannabidiol (CBD) is the main non-psychotropic component of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinson's disease. Cases summary Four patients treated with CBD had prompt and substantial reduction in the frequency of RBD-related events without side effects. What is new and conclusion This case series indicates that CBD is able to control the symptoms of RBD.

Original languageEnglish (US)
Pages (from-to)564-566
Number of pages3
JournalJournal of Clinical Pharmacy and Therapeutics
Volume39
Issue number5
DOIs
StatePublished - Oct 2014
Externally publishedYes

Keywords

  • Parkinson's disease
  • cannabidiol
  • rapid eye movement sleep behaviour disorder

Fingerprint

Dive into the research topics of 'Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series'. Together they form a unique fingerprint.

Cite this